Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm

Journal of Infection and Chemotherapy

Volumn 8, Issue 3, 2002, Pages 218-226

  Monden, Koichi ^a   Ando, Eiichi ^a   Iida, Maiko ^b   Kumon, Hiromi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

Biofilm; Fosfomycin; Ofloxacin; Pseudomonas aeruginosa

Indexed keywords

FOSFOMYCIN; OFLOXACIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BIOFILM; CELL KILLING; CELL MEMBRANE PERMEABILITY; DRUG POTENTIATION; GENETIC SUSCEPTIBILITY; GLYCOCALYX; NONHUMAN; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0036745739     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-002-0186-6     Document Type: Article

References (26)

1. Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 1987;237:1588-95.
2. Koch C, Hoiby N. Pathogenesis of cystic fibrosis. Lancet 1993;341:1065-9.
3. Kumon H. Pathogenesis and management of bacterial biofilms in the urinary tract. J Infect Chemother 1996;2:18-28.
4. Nickel JC, Costerton JW. Coagulase-negative Staphylococcus in chronic prostatitis. J Urol 1992;147:398-400.
5. Costerton JW. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. Trends Microbiol 2001;9:50-2.
6. Anwar H, Costerton JW. Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile biofilm cells of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1990;34:1666-71.
7. Yassien M, Khardori N, Ahmedy A, Toama M. Modulation of biofilms of Pseudomonas aeruginosa by quinolones. Antimicrob Agents Chemother 1995;39:2262-8.
8. Yanagihara K, Tomono K, Sawai T, Kuroki M, Kaneko Y, Kohno S, et al. Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation. J Antimicrob Chemother 2000;46:69-72.
9. Kumon H, Ono N, Iida M, Nickel JC. Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm. Antimicrob Agents Chemother 1995;39:1038-44.
10. Minuth JN, Musher DM, Thorsteinsson SB. Inhibition of the antibacterial activity of gentamicin by urine. J Infect Dis 1976;133:14-21.
11. Nickel JC, Ruseska I, Wright JB, Costerton JW. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother 1985;27:619-24.
12. Hirai K, Suzue S, Irikura T, Iyobe S, Mitsuhashi S. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1987;31:582-6.
13. Celesk RA, Robillard NJ. Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1989;33:1921-6.
14. Pascual A, Garcia I, Perea EJ. Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1989;33:653-6.
15. Watanabe T. Observation of Pseudomonas aeruginosa biofilm with confocal laser scanning microscope. Kansenshogaku Zasshi 1995;69:114-22.
16. Eng RH, Padberg FT, Smith SM, Tan EN, Cherubin CE. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother 1991;35:1824-8.
17. Reid G, Sharma S, Advikolanu K, Tieszer C, Martin RA. Bruce AW. Effects of ciprofloxacin, norfloxacin, and ofloxacin on in vitro adhesion and survival of Pseudomonas aeruginosa AK1 on urinary catheters. Antimicrob Agents Chemother 1994;38:1490-5.
18. van Anwar HBT, Dasgupta M, Lam K, Costerton JW. Interaction of biofilm bacteria with antibiotics in a novel in vitro chemostat system. Antimicrob Agents Chemother 1989;33:1824-6.
19. Costerton JW, Lam J, Lam K, Chan R. The role of the microcolony mode of growth in the pathogenesis of Pseudomonas aeruginosa infections. Rev Infect Dis 1983;5:S867-73.
20. Hoyle BD, Costerton JW. Bacterial resistance to antibiotics: the role of biofilms. Prog Drug Res 1991;37:91-105.
21. Figueredo VM, Neu HC. Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosis. J Antimicrob Chemother 1988;22:41-50.
22. Xiong YQ, Potel G, Caillon J, Stephant G, Jehl F, Bugnon D, et al. Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995;39:496-9.
23. Kumon H, Tomochika K, Matunaga T, Ogawa M, Ohmori H. A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides. Microbiol Immunol 1994;38:615-9.
24. Kahan FM, Kahan JS, Cassidy PJ, Kropp H. The mechanism of action of fosfomycin (phosphonomycin). Ann N Y Acad Sci 1974;235:364-86.
25. Inouye S, Watanabe T, Tsuruoka T, Kitasato I. An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditions. J Antimicrob Chemother 1989;24:657-66.
26. Freedberg WB, Lin EC. Three kinds of controls affecting the expression of the glp regulon in Escherichia coli. J Bacteriol 1973;115:816-23.